, Tracking Stock Market Picks
Enter Symbol:

down 99.93 %

NEUROGESX INC. (NGSX) rated Outperform with price target $10 by Wedbush

Posted on: Wednesday,  Feb 16, 2011  1:33 PM ET by Wedbush

Wedbush rated Outperform NEUROGESX INC. (OTCBB: NGSX) on 02/16/2011. Previously Wedbush rated Outperform NEUROGESX INC. (OTCBB: NGSX) on 05/03/2010.,
when the stock price was $10.38. Since then, NEUROGESX INC. has lost 99.94% as of 08/27/2015's recent price of $0.01.
If you would have followed the previous Wedbush 's recommendation on NGSX, you would have lost 99.93% of your investment in 1942 days.

NeurogesX, Inc. (NeurogesX) is a biopharmaceutical company focused on developing and commercializing pain management therapies. The Company is assembling a portfolio of pain management product candidates and is developing new therapies based on known chemical entities. Its initial focus is on the management of chronic peripheral neuropathic pain conditions. The Company?s most advanced product candidate, Qutenza, a dermal patch containing a high concentration of synthetic capsaicin, is designed to manage pain associated with peripheral neuropathic pain conditions. The Company submitted to the United States Food and Drug Administration?s (FDA) an new drug application (NDA) for Qutenza for the management of pain associated with postherpetic neuralgia (PHN), in October 2008 which was filed by the FDA in December 2008. The Company's Products include Qutenza, NGX-1998, Acetaminophen Prodrugs (NGX-1576, NGX-9674, NGX-5752) and Opioid Prodrugs (NGX-6052).

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/16/2011 1:33 PM Buy
4.50 10.00
as of 12/30/2011
1 Week down  -17.17 %
1 Month down  -10.86 %
3 Months down  -7.86 %
1 YTD down  -87.10 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/28/2010 9:25 AM Buy
6.50 13.00
5/3/2010 1:25 PM Buy
10.38 15.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy